Milk Transfer and Neonatal Safety of Tacrolimus
Authors:
Open Access
- 1 June 2003
- journal article
- case report
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 37 (6) , 815-818
Abstract
OBJECTIVE: To report the first case of tacrolimus measurement in human milk following maternal dosing in a woman who breast-fed while taking the medication. CASE REPORT: A 32-year-old white woman who had taken tacrolimus 0.1 mg/kg/d throughout pregnancy contacted the Motherisk Program at 35 weeks' gestation inquiring about the safety of breast-feeding during maternal tacrolimus therapy. After benefit–risk assessment, the mother decided to breast-feed the baby. METHODS: Manually expressed milk samples were collected over 12 hours following the first tacrolimus dose of the day; pre-dosing and 1-hour post-dosing blood concentrations were also determined. The samples were analyzed for tacrolimus by tandem-mass spectrometry. Breast milk and blood samples were collected at steady-state. RESULTS: The highest and mean concentrations of tacrolimus in milk were 0.57 and 0.429 ng/mL, respectively. From these measurements, the exclusively breast-fed infant would ingest, on average, 0.06 μg/kg/d, which corresponds to 0.06% of the mother's weight-adjusted dose. Given the low oral bioavailability of tacrolimus, the maximum amount the baby would receive is 0.02% of the mother's weight-adjusted dose. The milk-to-blood ratios of tacrolimus at pre-dosing and 1-hour post-dosing concentrations were calculated to be 0.08 and 0.09, respectively. At 2.5 months of age, the infant was developing well both physically and neurologically. COMMENT: This report is the first to measure tacrolimus concentrations in established human milk using tandem-mass spectrometry to detect drug while the infant was exclusively breast-fed by the mother, and in which the infant's growth and development were reported. CONCLUSIONS: Our results suggest that maternal therapy with tacrolimus for liver transplant may be compatible with breast-feeding.Keywords
This publication has 10 references indexed in Scilit:
- Comparison of an ELISA and an LC/MS/MS Method for Measuring Tacrolimus Concentrations and Making Dosage Decisions in Transplant RecipientsTherapeutic Drug Monitoring, 2002
- IMx tacrolimus II assay: is it reliable at low blood concentrations? A comparison with tandem MS/MSClinical Biochemistry, 2002
- Simultaneous simple and fast quantification of three major immunosuppressants by liquid chromatography—tandem mass-spectrometryClinical Biochemistry, 2001
- Tacrolimus metabolite cross-reactivity in different tacrolimus assaysClinical Biochemistry, 1998
- Pitfalls in Monitoring Tacrolimus (FK 506)Therapeutic Drug Monitoring, 1997
- PREGNANCY AFTER LIVER TRANSPLANTATION UNDER TACROLIMUS1Transplantation, 1997
- Clinical relevance of monitoring tacrolimus: comparison of microparticle enzyme immunoassay, enzyme-linked immunosorbent assay, and liquid chromatography mass spectrometry in renal transplant recipients converted from cyclosporine to tacrolimus.1996
- Consensus Document: Therapeutic Monitoring of Tacrolimus (FK-506)Therapeutic Drug Monitoring, 1995
- A Longitudinal Study of the Protein Content of Human Milk from Well-Nourished Swedish MothersAnnals of Nutrition and Metabolism, 1977
- Clinical and Chemical Studies in Human Lactation.--I, II, and IIIBMJ, 1954